Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Haematologica|January 8, 2026
Promoter hypermethylation as a reversible mechanism of resistance to GPRC5D-directed therapy in multiple myelomaSeungbin Han, Umair Munawar, Marietta Truger, et al.Hemasphere|July 12, 2024
Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myelomaLarissa Haertle, Umair Munawar, Hipólito N C Hernández, et al.Blood|June 30, 2023
Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysisAlexandra M Poos, Nina Prokoph, Moritz J Przybilla, et al.British Journal of Haematology|May 8, 2024
Changes in T-cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T-cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker studyXiang Zhou, Vivien Wagner, Lukas Scheller, et al.Cancers|January 21, 2023
Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple MyelomaLarissa Haertle, Natalia Buenache, Hipólito Nicolás Cuesta Hernández, et al.Biomarker Research|May 16, 2023
Bortezomib induced peripheral neuropathy and single nucleotide polymorphisms in PKNOX1Xiang Zhou, Seungbin Han, Nadine Cebulla, et al.Clinical Epigenetics|April 2, 2026
Promoter hypomethylation drives ABCB1-mediated carfilzomib resistance in multiple myelomaSeungbin Han, Larissa Haertle, Umair Munawar, et al.Blood|June 11, 2021
Cereblon enhancer methylation and IMiD resistance in multiple myelomaLarissa Haertle, Santiago Barrio, Umair Munawar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2022
Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple MyelomaLarissa Haertle, Santiago Barrio, Umair Munawar, et al.Communications Biology|December 22, 2023
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple MyelomaUmair Munawar, Xiang Zhou, Sabrina Prommersberger, et al.Pageof 3